缺氧位吸引和隔离与瘤相关的巨细胞和细胞毒性T细胞,并将它们重新编程为免疫抑制
Anirudh Sattiraju1, Sangjo Kang1, Bruno Giotti2
1Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Immunity
|July 14, 2023
概括
质母细胞瘤的进展涉及髓状细胞转移到缺氧区域,抑制免疫反应. 针对这些模式可能会改善脑癌治疗.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 质母细胞瘤 (GBM) 是一种致命的脑癌,其特征是免疫抑制.
- 驱动GBM相关免疫抑制的机制尚未完全理解.
研究的目的:
- 在GBM进展过程中调查瘤相关髓状细胞 (TAMs) 的空间分布.
- 阐明瘤缺氧和相关因素在GBM内的免疫细胞行为和免疫抑制中的作用.
主要方法:
- 追踪与 GBM 的血管变化相关的时空 TAM 模式.
- 使用光报道器 (UnaG) 监测瘤缺氧.
- 采用单细胞转录学来分析细胞状态和相互作用.
- 确定涉及TAM贩运和利基市场形成的关键分子因素 (CCL8,IL-1β).
主要成果:
- 在GBM进展过程中,TAMs从周围血管转移到低氧,血管贫困区域.
- 低毒性利基吸引和隔离TAM和细胞毒性T淋巴细胞 (CTL).
- 缺氧会将TAM和CTL重编程到一个免疫抑制状态.
- 化学因子CCL8和细胞因子IL-1β被确定为TAM贩运和伪化的关键因素.
结论:
- 瘤缺氧在协调TAM分布和GBM中的免疫抑制方面发挥着至关重要的作用.
- 已识别的分子机制提供了潜在的治疗点.
- 在低氧区中扰乱TAM模式可能提供一种改善质母细胞瘤控制的策略.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Stem Cell Niche
5.2K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.2K
Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K


